Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it significantly strengthens resilience, reduces operating costs, and enhances ...
Wave Life Sciences (WVE) stock analysis: low valuation (2.45x cash, no debt) vs. RNA therapy competition; key upside tied to WVE-N531 results. See more here.
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results